Press releases
- Hims & Hers Certified as a ‘Great Place to Work’
- Hims & Hers Welcomes Five New Experts to Its Medical Advisory Board
- Allermi Secures $3.5M in Seed Funding to Meet Growing Demand for Customized Approach to Allergy Symptoms
- Hims & Hers Announces New Anti-Dandruff Shampoo for Hims Customers
- Hims & Hers Appoints Senior Vice President of Mental Health Advancing Efforts to Provide the Highest Quality of Innovative Care for Anxiety and Depression
- Hims & Hers Health, Inc. Not Materially Impacted by Silicon Valley Bank Closure
- Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results
- Hims Launches Hard Mints – A Highly Personalized Treatment For Erectile Dysfunction
- Hims & Hers to Announce Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
- Hims & Hers Launches New Line of Volumizing Shampoos and Conditioners
More ▼
Key statistics
As of last trade Hims & Hers Health Inc (82W:DUS) traded at 8.74, -22.31% below its 52-week high of 11.25, set on Mar 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.74 |
---|---|
High | 8.74 |
Low | 8.74 |
Bid | 8.92 |
Offer | 9.26 |
Previous close | 8.52 |
Average volume | 1.07k |
---|---|
Shares outstanding | 208.46m |
Free float | 155.83m |
P/E (TTM) | -- |
Market cap | 1.99bn USD |
EPS (TTM) | -0.3214 USD |
Data delayed at least 15 minutes, as of Mar 27 2023 07:11 BST.
More ▼